bf/NASDAQ:UTRS_icon.png

NASDAQ:UTRS

Minerva Surgical, Inc.

  • Stock

USD

Market Cap

13.14M

Beta: -

Volume Today

1

Avg: 322.31K

PE Ratio

−0.20

PFCF: −0.18

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
7.47M
-
12.94M
73.19%
16.27M
25.69%
average payables
3.85M
-
3.57M
7.33%
3.22M
9.84%
average receivables
6.16M
-
7.84M
27.14%
7.27M
7.24%
book value per share
-11.03
-
-10.87
1.43%
6.29
157.84%
0.60
90.52%
capex per share
-0.01
-
-0.02
84.63%
-0.08
275.03%
-0.00
96.96%
capex to depreciation
-0.13
-
-0.06
51.91%
-0.05
14.10%
-0.01
87.72%
capex to operating cash flow
0.01
-
0.04
228.45%
0.03
29.48%
0.00
92.13%
capex to revenue
-0.01
-
-0.01
39.91%
-0.01
6.55%
-0.00
87.05%
cash per share
1.46
-
0.85
41.75%
5.79
580.52%
0.24
95.84%
days of inventory on hand
121.88
-
199.67
63.82%
265.24
32.84%
266.80
0.59%
days payables outstanding
107.72
-
68.62
36.30%
61.38
10.56%
44.40
27.67%
days sales outstanding
55.38
-
80.98
46.21%
51.08
36.92%
52.57
2.91%
debt to assets
1.63
-
1.06
34.98%
0.34
67.56%
0.58
68.00%
debt to equity
-0.37
-
-0.44
18.20%
0.89
304.00%
2.31
158.18%
dividend yield
earnings yield
-0.42
-
-0.10
76.22%
-0.60
498.65%
-5.30
790.05%
enterprise value
215.67M
-
263.52M
22.18%
34.71M
86.83%
39.18M
12.89%
enterprise value over ebitda
-12.22
-
-32.29
164.31%
-1.84
94.30%
-1.27
31.07%
ev to operating cash flow
-10.90
-
-21.53
97.56%
-1.55
92.80%
-1.10
28.97%
ev to sales
8.29
-
6.98
15.85%
0.67
90.45%
0.78
16.95%
free cash flow per share
-1.08
-
-0.62
42.36%
-3.27
426.24%
-1.24
62.22%
free cash flow yield
-0.12
-
-0.07
42.36%
-0.64
821.44%
-5.54
769.21%
graham net net
-11.80
-
-13.98
18.44%
-2.43
82.58%
-1.07
55.91%
graham number
30.57
-
14.80
51.58%
20.81
40.63%
3.99
80.85%
income quality
0.38
-
0.67
76.26%
1.04
55.56%
1.04
0.00%
intangibles to total assets
0
-
0.47
Infinity%
0.30
35.17%
0.39
27.91%
interest coverage
-1.12
-
-1.27
13.49%
-2.49
96.03%
-9.59
285.90%
interest debt per share
5.04
-
5.36
6.40%
7.30
36.09%
1.49
79.60%
inventory turnover
2.99
-
1.83
38.96%
1.38
24.72%
1.37
0.58%
invested capital
-0.37
-
-0.44
18.20%
0.89
304.00%
2.31
158.18%
market cap
166.87M
-
183.59M
10.02%
36.04M
80.37%
6.44M
82.14%
net current asset value
-207.39M
-
-268.44M
29.43%
4.02M
101.50%
-15.60M
488.45%
net debt to ebitda
-2.76
-
-9.79
254.24%
0.07
100.72%
-1.06
1,598.97%
net income per share
-3.76
-
-0.90
76.22%
-3.06
241.90%
-1.18
61.32%
operating cash flow per share
-1.07
-
-0.60
43.79%
-3.19
431.84%
-1.23
61.31%
payables turnover
3.39
-
5.32
56.98%
5.95
11.80%
8.22
38.25%
receivables turnover
6.59
-
4.51
31.60%
7.15
58.52%
6.94
2.83%
research and ddevelopement to revenue
0.04
-
0.09
144.85%
0.10
15.40%
0.11
6.55%
return on tangible assets
-1.50
-
-0.37
75.02%
-0.27
28.26%
-0.81
202.30%
revenue per share
1.40
-
1.85
31.97%
7.43
301.32%
1.75
76.50%
roe
0.34
-
0.08
75.87%
-0.49
691.08%
-1.99
307.97%
roic
0.20
-
0.12
40.06%
-0.35
384.35%
-0.54
54.80%
sales general and administrative to revenue
0.32
-
0.22
32.52%
0.43
95.81%
0.29
32.89%
shareholders equity per share
-11.03
-
-10.87
1.43%
6.29
157.84%
0.60
90.52%
stock based compensation to revenue
0.02
-
0.02
0.67%
0.13
475.93%
0.14
6.04%
tangible asset value
-204.52M
-
-264.95M
29.55%
9.13M
103.45%
-9.60M
205.07%
tangible book value per share
-11.03
-
-12.99
17.74%
1.30
110.03%
-0.33
125.57%
working capital
28.59M
-
12.15M
57.49%
52.38M
331.00%
21.84M
58.31%

All numbers in USD (except ratios and percentages)